Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ALNY
ALNY logo

ALNY

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ALNY News

Alnylam Advances Early Diagnosis and Care for ATTR-CM

6d agoNewsfilter

Analysis of IBB ETF Trading Dynamics

Mar 20 2026NASDAQ.COM

Analysis of IBB ETF Trading Dynamics

Mar 11 2026NASDAQ.COM

BridgeBio's Promising Biotech Pipeline Highlighted by William Blair

Mar 10 2026Benzinga

Tenaya Partners with Alnylam for Heart Drug Development

Mar 06 2026stocktwits

Health Care Stocks Decline, NYSE Health Care Index Drops 2.3%

Mar 05 2026Yahoo Finance

Tenaya Therapeutics Partners with Alnylam for Genetic Research

Mar 05 2026Benzinga

Tenaya Therapeutics Partners with Alnylam for Up to $1.1B Cardiovascular Drug Collaboration

Mar 05 2026seekingalpha

Tenaya and Alnylam Enter Research Collaboration Agreement

Mar 05 2026NASDAQ.COM

Tenaya and Alnylam Forge Collaboration for Genetic Heart Disease Targets

Mar 05 2026Globenewswire

Tenaya and Alnylam Forge Collaboration for Genetic Heart Disease Targets

Mar 05 2026Newsfilter

Alnylam Pharmaceuticals Rated as One of the Unstoppable Stocks to Buy for Next 3 Years

Mar 01 2026Yahoo Finance

Shifting Trends in Biotechnology Mergers and Acquisitions

Feb 19 2026Globenewswire

Alnylam Pharmaceuticals Price Target Downgrade Analysis

Feb 19 2026Yahoo Finance

Analysts Bullish on Alnylam Stock Outlook

Feb 17 2026Fool

Alnylam Pharmaceuticals Reports Mixed Q4 and 2025 Results

Feb 13 2026NASDAQ.COM